Effect of intracerebroventricular 6-hydroxydopamine (6-HODA) on the angiotensinogen concentration of the brain.
D000808:Angiotensinogen / Q000032:analysis* / Q000134:cerebrospinal fluid; D000809:Angiotensins / Q000032:analysis*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D001933:Brain Stem / Q000032:analysis; D002531:Cerebellum / Q000032:analysis; D002540:Cerebral Cortex / Q000032:analysis; D006892:Hydroxydopamines / Q000494:pharmacology*; D007031:Hypothalamus / Q000032:analysis; D008297:Male; D009638:Norepinephrine / Q000502:physiology*; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains
D000809:Angiotensins; D006892:Hydroxydopamines; D000808:Angiotensinogen; D016627:Oxidopamine; D009638:Norepinephrine